Abstract
Background Diabetes mellitus and hypertension are increasingly prevalent non-communicable diseases that often coexist due to their interrelated pathophysiology and commonalities of risk factors. Effective management of these two comorbid conditions often involves polypharmacy, defined as the concurrent use of five or more medications, which places a substantial pill burden on patients and demands consistent medication adherence for effective disease control. In Tanzania, where access to chronic care services remains constrained and out-of-pocket medication costs can be substantial, understanding the drivers of non-adherence is considered imperative.. Limited data exist on the extent of polypharmacy and its impact on adherence among Tanzanian patients with these comorbidities. This study therefore aimed at evaluating the prevalence of polypharmacy and its impact on medication medication adherence among this population.
Methodology A cross-sectional study involving 396 outpatients was conducted at Muhimbili National Hospital. Consecutive sampling was used to recruit eligible participants. Data were collected using a structured questionnaire that captured information on socio-demographics, clinical characteristics, and adherence behaviors. Polypharmacy was defined as the concurrent use of five or more medications. Medication adherence was assessed using the Medication Adherence Report Scale (MARS-5). Modified Poisson regression with robust standard errors was performed to identify factors associated with medication adherence and to estimate crude and adjusted prevalence ratios (cPR and aPR) with 95% confidence intervals.
Results 71% of the study participants were on five or more medications, indicating high polypharmacy prevalence, with a median of six medications. Medication adherence was reported at 55.1%. Among participants with lower adherence, a higher proportion had elevated fasting glucose for moderate (APR: 0.83, P = 0.001) and high fasting glucose (APR: 0.66, P < 0.001), and uncontrolled blood pressure while herbal medicine use (APR: 0.72, P < 0.001) was identified as contributing factor to lower adherence..
Conclusion This study reveals a high prevalence of polypharmacy with moderate medication adherence among patients with comorbid T2DM and hypertension. These findings underscore the need for targeted interventions such as structured patient education, pharmacist-led medication reviews, and polypharmacy rationalization to improve medication adherence and clinical outcomes in this population.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Muhimbili University of Health and Allied Sciences (MUHAS) Research and Ethics Committee (Certificate Ref. No. DA.282/298/01L/902). Permission to conduct the study was also obtained from Muhimbili National Hospital, Upanga, and Mloganzila. Informed consent was obtained from all participants before enrollment. To ensure confidentiality, each participant was assigned a unique study identification number, and all documents, including consent forms and data collection tools, were securely stored. The information gathered was solely for the purposes of this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
List of Abbreviations
- DBP
- Diastolic Blood Pressure
- IDF
- International Diabetes Federation
- LMICs
- Low- and Middle-Income Countries
- MARS
- Medication Adherence Reporting Scale
- SBP
- Systolic Blood Pressure
- T2DM
- Type 2 Diabetes Mellitus
- WHO
- World Health Organization
